|   ISPA-28结构式   | 常用名 | ISPA-28 | 英文名 | ISPA-28 | 
|---|---|---|---|---|
| CAS号 | 1006335-39-2 | 分子量 | 408.454 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C21H24N6O3 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A | 
| ISPA-28用途ISPA-28 是特异性的疟原虫表面阴离子通道 (PSAC) 拮抗剂。ISPA-28 直接可逆的与CLAG3 结合。 | 
| 英文名 | N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-4,5-dihydro-1,2-oxazole-5-carboxamide | 
|---|---|
| 英文别名 | 更多 | 
| 描述 | ISPA-28 是特异性的疟原虫表面阴离子通道 (PSAC) 拮抗剂。ISPA-28 直接可逆的与CLAG3 结合。 | 
|---|---|
| 相关类别 | |
| 体外研究 | ISPA-28仅作为Dd2通道的抑制剂有效(Dd2和HB3通道的K0.5值分别为56 nM和43μM)[2]。 | 
| 参考文献 | [1]. Sanjay A Desai, et al. Ion and Nutrient Uptake by Malaria Parasite-Infected Erythrocytes. | 
| 密度 | 1.4±0.1 g/cm3 | 
|---|---|
| 分子式 | C21H24N6O3 | 
| 分子量 | 408.454 | 
| 精确质量 | 408.190979 | 
| LogP | 0.18 | 
| 折射率 | 1.672 | 
| 危险品运输编码 | NONH for all modes of transport | 
|---|
| An epigenetic antimalarial resistance mechanism involving parasite genes linked to nutrient uptake. J. Biol. Chem. 288(27) , 19429-40, (2013) Acquired antimalarial drug resistance produces treatment failures and has led to periods of global disease resurgence. In Plasmodium falciparum, resistance is known to arise through genome-level chang... | |
| Malaria parasite mutants with altered erythrocyte permeability: a new drug resistance mechanism and important molecular tool. Future Microbiol. 5(1) , 81-97, (2010) Erythrocytes infected with plasmodia, including those that cause human malaria, have increased permeability to a diverse collection of organic and inorganic solutes. While these increases have been kn... | 
| 5-Isoxazolecarboxamide, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-4,5-dihydro- | 
| N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-4,5-dihydro-1,2-oxazole-5-carboxamide | 
| MFCD08106635 |